In vivo investigation of thiomer - Polyvinylpyrrolidon nanoparticles using magnetic resonance imaging

Journal of Pharmaceutical Sciences

Volumn 99, Issue 4, 2010, Pages 2008-2017

  Albrecht, K ^a   Greindl, M ^a   Deutel, B ^b   Kremser, C ^c   Wolf, C ^c   Talasz, H ^c   Stollenwerk, M M ^c   Debbage, P ^c   Bernkop Schnurch A ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Thiomatrix Forschungs und Beratungs GmbH   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Absorption enhancer; Nanoparticles; Oral drug delivery; Polymeric drug delivery; Renal excretion

Indexed keywords

CYSTEINE; GADOLINIUM PENTETATE; POLYACRYLIC ACID; POVIDONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; DRUG UPTAKE; IN VIVO STUDY; KIDNEY CLEARANCE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; RAT; STOMACH MUCOSA;

EID: 77949822115     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21969     Document Type: Article

References (24)

1. Ponchel G, Irache J. 1998. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 34:191-219.
2. Horn JR, Howden CW. 2005. Review article: Similarities and differences among delayed-release proton-pump inhibitor formulations. Aliment Pharmacol Ther 22:20-24.
3. Klausner EA, Lavy E, Stepensky D, Friedman M, Hoffman A. 2002. Novel gastroretentive dosage forms: Evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res 19:1516-1523.
4. Bernkop-Schnürch A, Pinter Y, Guggi D, Kahlbacher H, Schoffmann G, Schuh M, Schmerold I, Del Curto MD, D'Antonio M, Esposito P, Huck C. 2005. The use of thiolated polymers as carrier matrix in oral peptide delivery - Proof of concept. J Control Release 106:26-33.
5. Streubel A, Siepmann J, Bodmeier R. 2006. Gastroretentive drug delivery systems. Expert Opin Drug Deliv 3:217-233.
6. Clausen AE, Bernkop-Schnürch A. 2000. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci 89:1253-1261.
7. Greindl M, Föger F, Hombach J, Bernkop-Schnürch A. 2009. In vivo evaluation of thiolated poly(acrylic acid) as a drug absorption modulator for MRP efflux pump substrates. Eur J Pharm Biopharm 72:561-566.
8. Bernkop-Schnürch A, Obermair K, Greimel A, Palmberger TF. 2006. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin. Amino Acids 30:417-423.
9. Albrecht K, Greindl M, Kremser C, Wolf C, Debbage P, Bernkop- Schnürch A. 2006. Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection. J Control Release 115:78-84.
10. Marschütz MK, Bernkop-Schnürch A. 2002. Thiolated polymers: Self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur J Pharm Sci 15:387-394.
11. Leitner VM, Marschütz MK, Bernkop-Schnürch A. 2003. Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass. Eur J Pharm Sci 18:89-96.
12. Hornof H, Weyenberg W, Ludwig A, Bernkop-Schnürch A. 2003. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): Development and in vivo evaluation in humans. J Control Release 89:419-428.
13. Chun MK, Cho CS, Choi HK. 2002. Mucoadhesive drug carrier based on interpolymer complex of poly(vinyl pyrrolidone) and poly(acrylic acid) prepared by template polymerization. J Control Release 81:327-334.
14. Kaminsky S, Laniado M, Gogoll M, Kornmesser W, Clauss W, Langer M, Claussen C, Felix R. 1991. Gadopentetate dimeglumine as a bowel contrast agent: Safety and efficacy. Radiology 178:503-508.
15. Bridot JL, Faure AC, Laurent S, Riviere C, Billotey C, Hiba B, Janier M, Josserand V, Coll JL, Elst LV, Muller R, Roux S, Perriat P, Tillement O. 2007. Hybrid gadolinium oxide nanoparticles: Multimodal contrast agents for in vivo imaging. J Am Chem Soc 129:5076-5084.
16. Briley-Saebo KC, Amirbekian V, Mani V, Aguinaldo JG, Vucic E, Carpenter D, Amirbekian S, Fayad ZA. 2006. Gadolinium mixed-micelles: Effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis. Magn Reson Med 56:1336-1346.
17. Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL. 2006. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: Comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 111:343-351.
18. Liang L, D'Haese PC, Lamberts LV, Van de Vyver FL, De Broe ME. 1991. Determination of gadolinium in biological materials using graphite furnace atomic absorption spectrometry with a tantalum boat after solvent extraction. Anal Chem 63:423-427.
19. Bernkop-Schnürch A, Weithaler A, Albrecht K, Greimel A. 2006. Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int J Pharm 317:76-81.
20. Waynforth HB, Flecknell PA. 1992. Experimental and surgical technique in the rat. New York: Academic Press. pp 19-26.
21. Haase A, Matthaei D, Bartkowski R, Duhmke E, Leibfritz D. 1989. Inversion recovery snapshot FLASH MR imaging. J Comput Assist Tomogr 13:1036-1040.
22. Deichmann R, Haase A. 1992. Quantification of T1 values by SNAPSHOT FLASH NMR imaging. J Magn Reson 96:608-612.
23. Kremser C, Trieb T, Rudisch A, Judmaier W, de Vries A. 2007. Dynamic T1 mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: Sequence implementation and data. J Magn Reson Imaging 26:662-671.
24. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. 1984. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol: 142(3):619-24.